International Clinical Trial: Study on the Expression Characteristics of Key Molecules in the TLR2 Signaling Pathway in Children with Mycoplasma Pneumoniae Pneumonia and Their Predictive Value for Severe MPP

Geneva, Feb. 13 -- International Clinical Trials Registry received information related to the study (ChiCTR2600118508) titled 'Study on the Expression Characteristics of Key Molecules in the TLR2 Signaling Pathway in Children with Mycoplasma Pneumoniae Pneumonia and Their Predictive Value for Severe MPP' on Feb. 6.

Study Type: Observational study

Study Design: Case-Control study

Primary Sponsor: Sichuan Provincial Maternity and Child Health Care Hospital

Condition: Mycoplasma Pneumoniae Pneumonia

Intervention: Mild MPP Group:no Healthy Control Group:no

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-03-01

Target Sample Size: Mild MPP Group:120;Healthy Control Group:60;Severe MPP Group:60;

Coun...